Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 4 studies | 26% ± 9% | |
epithelial cell | 3 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of RMI2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 523.14 | 1803 / 1809 | 95% | 14.48 | 450 / 472 |
ovary | 93% | 203.08 | 168 / 180 | 100% | 18.90 | 428 / 430 |
lung | 78% | 125.98 | 453 / 578 | 96% | 19.44 | 1114 / 1155 |
bladder | 76% | 135.38 | 16 / 21 | 98% | 24.63 | 496 / 504 |
intestine | 75% | 223.14 | 721 / 966 | 98% | 19.85 | 514 / 527 |
stomach | 67% | 135.07 | 241 / 359 | 98% | 17.51 | 280 / 286 |
esophagus | 57% | 242.45 | 821 / 1445 | 98% | 17.52 | 180 / 183 |
uterus | 55% | 70.80 | 94 / 170 | 100% | 45.09 | 458 / 459 |
thymus | 64% | 77.96 | 418 / 653 | 91% | 14.46 | 548 / 605 |
kidney | 89% | 152.58 | 79 / 89 | 58% | 4.86 | 526 / 901 |
breast | 52% | 58.85 | 238 / 459 | 95% | 17.64 | 1062 / 1118 |
prostate | 82% | 121.46 | 201 / 245 | 46% | 3.11 | 233 / 502 |
pancreas | 40% | 37.23 | 131 / 328 | 87% | 10.54 | 154 / 178 |
adrenal gland | 75% | 84.56 | 193 / 258 | 30% | 5.46 | 70 / 230 |
brain | 62% | 108.81 | 1640 / 2642 | 41% | 4.03 | 286 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.94 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.30 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.70 | 1 / 1 |
spleen | 100% | 225.96 | 240 / 241 | 0% | 0 | 0 / 0 |
liver | 29% | 47.00 | 66 / 226 | 50% | 5.59 | 201 / 406 |
peripheral blood | 69% | 478.28 | 641 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 49% | 3.11 | 39 / 80 |
adipose | 49% | 50.90 | 584 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 22% | 20.15 | 300 / 1335 | 0% | 0 | 0 / 0 |
heart | 22% | 19.60 | 186 / 861 | 0% | 0 | 0 / 0 |
muscle | 17% | 15.20 | 134 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0006281 | Biological process | DNA repair |
GO_0043007 | Biological process | maintenance of rDNA |
GO_0071139 | Biological process | resolution of DNA recombination intermediates |
GO_0006260 | Biological process | DNA replication |
GO_2000042 | Biological process | negative regulation of double-strand break repair via homologous recombination |
GO_0033045 | Biological process | regulation of sister chromatid segregation |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031422 | Cellular component | RecQ family helicase-topoisomerase III complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RMI2 |
Protein name | RecQ mediated genome instability 2 RecQ-mediated genome instability protein 2 (hRMI2) (BLM-associated protein of 18 kDa) (BLAP18) |
Synonyms | C16orf75 |
Description | FUNCTION: Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates. It is required to regulate sister chromatid segregation and to limit DNA crossover. Essential for the stability, localization, and function of BLM, TOP3A, and complexes containing BLM. In the RMI complex, it is required to target BLM to chromatin and stress-induced nuclear foci and mitotic phosphorylation of BLM. . |
Accessions | ENST00000572173.1 [Q96E14-2] ENST00000312499.6 [Q96E14-1] I3L2E0 ENST00000576027.1 A0A3B3ISX4 Q96E14 ENST00000648619.1 |